Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Leukemia ; 36(5): 1324-1335, 2022 05.
Article in English | MEDLINE | ID: mdl-35149845

ABSTRACT

Interactions between chronic lymphocytic leukemia (CLL) cells and T-cell subsets in the lymph node microenvironment are thought to play a central role in disease biology. To study these interactions in a model of the CLL lymph node microenvironment, we characterized T-cell subsets in CLL nurselike cell (NLC) co-cultures. We focused on T-follicular helper (Tfh) cells, which are characterized by CXCR5 expression and localization to B-cell follicles. In co-cultures from 28 different CLL patients, we detected an expansion of Tfh cells based on PD-1, BCL6, and ICOS expression, with increased IL-21 and downmodulated CD40L surface expression. Regulatory T cells (Treg), which promote immune tolerance, also expanded in NLC co-cultures. T-cell receptor (TR) gene repertoire analyses confirmed the clonal expansion of CD4+ T cells, with an enrichment of TR clonotypes commonly expanded also in primary CLL samples. Multicolor confocal microscopy revealed that Tfh, but not Treg co-localize with proliferating CLL cells in CLL lymph node sections. Collectively, these data provide new insight into the cellular and molecular cross-talk between CLL and T-cell subsets, resulting in clonal expansion of T-helper cells and interaction of Tfh cells with proliferating CLL cells which may open new avenues for therapeutic targeting.


Subject(s)
Leukemia, Lymphocytic, Chronic, B-Cell , T Follicular Helper Cells , Coculture Techniques , Humans , Leukemia, Lymphocytic, Chronic, B-Cell/pathology , Receptors, CXCR5/metabolism , T-Lymphocytes, Helper-Inducer , Tumor Microenvironment
2.
Am J Physiol Endocrinol Metab ; 305(1): E41-9, 2013 Jul 01.
Article in English | MEDLINE | ID: mdl-23651845

ABSTRACT

In the present work, we investigated the effect of 17ß-estradiol (E2) and basic fibroblast growth factor 2 (FGF2) on the lactotroph cell-proliferative response and the related membrane-initiated signaling pathway. Anterior pituitary mixed-cell cultures of random, cycling 3-mo-old female rats were treated with 10 nM E2, E2 membrane-impermeable conjugated BSA (E2-BSA), PPT (ERα agonist), and DPN (ERß agonist) alone or combined with FGF2 (10 ng/ml) for 30 min or 4 h. Although our results showed that the uptake of BrdU into the nucleus of lactotrophs was not modified by E2 or FGF2 alone, a significant increase in the lactotroph uptake of BrdU was observed after E2/FGF2 coincubation, with this effect being mimicked by PPT/FGF2. These proliferative effects were blocked by ICI 182,780 or PD-98059. The involvement of membrane ER in the proliferative response of prolactin cells induced by the steroid and FGF2 coincubation was confirmed using E2-BSA, and the association between ERα and FGF receptor was observed after E2/FGF2 treatment by immunoprecipitation. A significant increase in the ERK1/2 expression was noted after E2, E2-BSA, PPT, and FGF2 alone, which was more noticeable after E2-BSA/FGF2, E2/FGF2, or PPT/FGF2 treatments. This study provides evidence that E2 and FGF2 exert a cooperative effect on the lactotroph proliferation principally by signaling initiated at the plasma membrane triggering a genomic effect mediated by MEK/ERK1/2, a common signaling pathway, that finally regulates the lactotroph population, thus contributing to pituitary plasticity.


Subject(s)
Cell Membrane/metabolism , Estradiol/metabolism , Fibroblast Growth Factor 2/metabolism , Lactotrophs/metabolism , MAP Kinase Signaling System/physiology , Pituitary Gland, Anterior/metabolism , Animals , Cell Proliferation/drug effects , Drug Synergism , Estradiol/pharmacology , Estrogen Receptor alpha/metabolism , Female , Fibroblast Growth Factor 2/pharmacology , Lactotrophs/cytology , MAP Kinase Signaling System/drug effects , Pituitary Gland, Anterior/cytology , Primary Cell Culture , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...